Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palifermin for Oral Mucositis in Head and Neck Cancer
NCT00101582Phase 3Completed
- Sponsor
- Sobi
- Start
- Aug 2005
- Primary completion
- Sep 2007
- Modality
- Cytokines & Interferons
01
Overview
Phase 3, randomised, double-blind trial in oral mucositis (OM) comparing Palifermin with Placebo (2 arms). Primary endpoint: Number of Participants With Severe (Grade 3 or 4) Oral Mucositis. Started Aug 2005; status: completed.
02
Drugs
palifermin
03
Conditions
oral mucositis (OM)
Beyond the preview
Go deeper on NCT00101582.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00101582.